TY - JOUR
T1 - Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010
AU - North American Aids Cohort Collaboration On Research And Design (na-Accord) Of IeDEA
AU - Buchacz, Kate
AU - Lau, Bryan
AU - Jing, Yuezhou
AU - Bosch, Ronald
AU - Abraham, Alison G.
AU - Gill, M. John
AU - Silverberg, Michael J.
AU - Goedert, James J.
AU - Sterling, Timothy R.
AU - Althoff, Keri N.
AU - Martin, Jeffrey N.
AU - Burkholder, Greer
AU - Gandhi, Neel
AU - Samji, Hasina
AU - Patel, Pragna
AU - Rachlis, Anita
AU - Thorne, Jennifer E.
AU - Napravnik, Sonia
AU - Henry, Keith
AU - Mayor, Angel
AU - Gebo, Kelly
AU - Gange, Stephen J.
AU - Moore, Richard D.
AU - Brooks, John T.
AU - Kirk, Gregory D.
AU - Benson, Constance A.
AU - Bosch, Ronald J.
AU - Boswell, Stephen
AU - Mayer, Kenneth H.
AU - Grasso, Chris
AU - Hogg, Robert S.
AU - Harrigan, P. Richard
AU - Montaner, Julio S.G.
AU - Cescon, Angela
AU - Carey, John T.
AU - Rodriguez, Benigno
AU - Horberg, Michael A.
AU - Jacobson, Lisa P.
AU - D'Souza, Gypsyamber
AU - Klein, Marina B.
AU - Rourke, Sean B.
AU - Burchell, Ann N.
AU - Rachlis, Anita R.
AU - Hunter-Mellado, Robert F.
AU - Mayor, Angel M.
AU - Deeks, Steven G.
AU - Saag, Michael S.
AU - Mugavero, Michael J.
AU - Willig, James
AU - Anastos, Kathryn
N1 - Funding Information:
This work was supported by NIH (grants U01AI069918, F31DA037788, G12MD007583, K01AI093197, K23EY013707, K24DA000432, K24AI065298, KL2TR000421, M01RR000052, N02CP055504, P30AI027757, P30AI027763, P30AI027767, P30AI036219, P30AI050410, P30AI094189, P30AI110527, P30MH62246, 01AA016893, R01CA165937, R01DA004334, R01DA011602, R01DA012568, R24AI067039, U01AA013566, U01AA020790, U01AI031834, U01AI034989, U01AI034993, U01AI034994, U01AI035004, U01AI035039, U01AI035040, U01AI035041, U01AI035042, U01AI037613, U01AI037984, U01AI038855, U01AI038858, U01AI042590, U01AI068634, U01AI068636, U01AI069432, U01AI069434, U01AI103390, U01AI103397, U01AI103401, U01AI103408, U01DA036935, U01HD032632, U10EY008057, U10EY008052, U10EY008067, U24AA020794, U54MD007587, UL1RR024131, UL1TR000004, UL1TR000083, UL1TR000454, UM1AI035043, Z01CP010214 and Z01CP010176); the CDC (contract CDC-200-2006-18797 and CDC-200-2015-63931); the Agency for Healthcare Research and Quality (contract 90047713); the Health Resources and Services Administration (contract 90051652); Canadian Institutes of Health Research (grants CBR- 86906, CBR-94036, HCP-97105 and TGF-96118); Ontario Ministry of Health and Long Term Care; and the Government of Alberta, Canada. Additional support was provided by the Intramural Research Program of the National Cancer Institute.
Publisher Copyright:
© 2016 Published by Oxford University Press for the Infectious Diseases Society of America.
PY - 2016/9/15
Y1 - 2016/9/15
N2 - Background. There are few recent data on the rates of AIDS-defining opportunistic infections (OIs) among human immunodeficiency virus (HIV)-infected patients in care in the United States and Canada. Methods. We studiedHIV-infected participants in 16 cohorts in the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) during 2000-2010. After excluding 16 737 (21%) with any AIDS-defining clinical events documented before NA-ACCORD enrollment, we analyzed incident OIs among the remaining 63 541 persons, most of whom received antiretroviral therapy during the observation. We calculated incidence rates per 100 person-years of observation (hereafter, "person-years") with 95% confidence intervals (CIs) for the first occurrence of any OI and select individual OIs during 2000-2003, 2004-2007, and 2008-2010. Results. A total of 63 541 persons contributed 261 573 person-years, of whom 5836 (9%) developed at least 1 OI. The incidence rate of any first OI decreased over the 3 observation periods, with 3.0 cases, 2.4 cases, and 1.5 cases per 100 person-years of observation during 2000-2003, 2004-2007, and 2008-2010, respectively (Ptrend<.001); the rates of most individual OIs decreased as well. During 2008-2010, the leading OIs included Pneumocystis jiroveci pneumonia, esophageal candidiasis, and disseminated Mycobacterium avium complex or Mycobacterium kansasii infection. Conclusions. For HIV-infected persons in care during 2000-2010, rates of first OI were relatively low and generally declined over this time.
AB - Background. There are few recent data on the rates of AIDS-defining opportunistic infections (OIs) among human immunodeficiency virus (HIV)-infected patients in care in the United States and Canada. Methods. We studiedHIV-infected participants in 16 cohorts in the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) during 2000-2010. After excluding 16 737 (21%) with any AIDS-defining clinical events documented before NA-ACCORD enrollment, we analyzed incident OIs among the remaining 63 541 persons, most of whom received antiretroviral therapy during the observation. We calculated incidence rates per 100 person-years of observation (hereafter, "person-years") with 95% confidence intervals (CIs) for the first occurrence of any OI and select individual OIs during 2000-2003, 2004-2007, and 2008-2010. Results. A total of 63 541 persons contributed 261 573 person-years, of whom 5836 (9%) developed at least 1 OI. The incidence rate of any first OI decreased over the 3 observation periods, with 3.0 cases, 2.4 cases, and 1.5 cases per 100 person-years of observation during 2000-2003, 2004-2007, and 2008-2010, respectively (Ptrend<.001); the rates of most individual OIs decreased as well. During 2008-2010, the leading OIs included Pneumocystis jiroveci pneumonia, esophageal candidiasis, and disseminated Mycobacterium avium complex or Mycobacterium kansasii infection. Conclusions. For HIV-infected persons in care during 2000-2010, rates of first OI were relatively low and generally declined over this time.
KW - AIDS-related opportunistic infections
KW - CD4 T-lymphocyte count
KW - HIV cohort studies
KW - combination antiretroviral therapy
KW - epidemiology
KW - incidence
KW - prophylaxis
UR - http://www.scopus.com/inward/record.url?scp=84985036608&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84985036608&partnerID=8YFLogxK
U2 - 10.1093/infdis/jiw085
DO - 10.1093/infdis/jiw085
M3 - Article
C2 - 27559122
AN - SCOPUS:84985036608
SN - 0022-1899
VL - 214
SP - 862
EP - 872
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 6
ER -